Radionuclide-based theranostics — a promising strategy for lung cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Radionuclide-based theranostics — a promising strategy for lung cancer
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 50, Issue 8, Pages 2353-2374
Publisher
Springer Science and Business Media LLC
Online
2023-03-27
DOI
10.1007/s00259-023-06174-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of Small Cell Lung Cancer
- (2022) Yaron Gesthalter et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Envafolimab: First Approval
- (2022) Anthony Markham DRUGS
- Preclinical and exploratory human studies of novel 68Ga-labeled D-peptide antagonist for PET imaging of TIGIT expression in cancers
- (2022) Xiaobo Wang et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Visualizing dynamic changes in PD-L1 expression in non-small cell lung carcinoma with radiolabeled recombinant human PD-1
- (2022) Haiming Luo et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Tumor angiogenesis at baseline identified by 18F-Alfatide II PET/CT may predict survival among patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
- (2022) Yuchun Wei et al. Journal of Translational Medicine
- Higher accuracy of [68 Ga]Ga-DOTA-FAPI-04 PET/CT comparing with 2-[18F]FDG PET/CT in clinical staging of NSCLC
- (2022) Xin Zhou et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy
- (2022) Dirk Zboralski et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments
- (2022) Mehdi Arbabi-Ghahroudi INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- How to explain the sensitivity of DNA double-strand breaks yield to 125I position?
- (2022) Mario Enrique Alcocer Ávila et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- CD133 as a Biomarker for an Autoantibody-to-ImmunoPET Paradigm for the Early Detection of Small Cell Lung Cancer
- (2022) Andrew G. Kunihiro et al. JOURNAL OF NUCLEAR MEDICINE
- Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms using 68Ga-PentixaFor PET
- (2022) Andreas K. Buck et al. JOURNAL OF NUCLEAR MEDICINE
- TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy
- (2022) Eugene Y Chiang et al. Journal for ImmunoTherapy of Cancer
- Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors
- (2022) Sara Pusceddu et al. JAMA Network Open
- The Development of Positron Emission Tomography Tracers for In Vivo Targeting the Kinase Domain of the Epidermal Growth Factor Receptor
- (2022) Antonia Högnäsbacka et al. Pharmaceuticals
- PET Imaging of Lung Cancers in Precision Medicine: Current Landscape and Future Perspective
- (2022) Qing Wang et al. MOLECULAR PHARMACEUTICS
- 68Ga-Labeled Cystine Knot Peptide Targeting Integrin αvβ6 for Lung Cancer PET Imaging
- (2022) Jingyun Ren et al. MOLECULAR PHARMACEUTICS
- Research progress and applications of nanobody in human infectious diseases
- (2022) Yaxian Mei et al. Frontiers in Pharmacology
- PET imaging of fibroblast activation protein in various types of cancers by using 68Ga-FAP-2286: Comparison with 18F-FDG and 68Ga-FAPI-46 in a single-center, prospective study
- (2022) Yizhen Pang et al. JOURNAL OF NUCLEAR MEDICINE
- The role of PD-1/PD-L1 and application of immune-checkpoint inhibitors in human cancers
- (2022) Qing Tang et al. Frontiers in Immunology
- [177Lu]Lu-FAP-2286 therapy in a case of right lung squamous cell carcinoma with systemic metastases
- (2022) Zijuan Rao et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Long-term survival in extensive-stage small-cell lung cancer treated with different immune checkpoint inhibitors in multiple-line therapies: A case report and literature review
- (2022) Xu Zhang et al. Frontiers in Immunology
- Preclinical PET imaging with the novel human antibody 89Zr-DFO-REGN3504 sensitively detects PD-L1 expression in tumors and normal tissues
- (2021) Marcus P Kelly et al. Journal for ImmunoTherapy of Cancer
- Treatment of Advanced Gastro-Entero-Pancreatic Neuro-Endocrine Tumors: A Systematic Review and Network Meta-Analysis of Phase III Randomized Controlled Trials
- (2021) Claudio Ricci et al. Cancers
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004)
- (2021) Hironori Takagi et al. LUNG CANCER
- Preliminary Study of a 1,5-Benzodiazepine-Derivative Labelled with Indium-111 for CCK-2 Receptor Targeting
- (2021) Marco Verona et al. MOLECULES
- Targeted α-therapy in non-prostate malignancies
- (2021) Hossein Jadvar et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Preclinical evaluation of [225Ac]Ac-DOTA-TATE for treatment of lung neuroendocrine neoplasms
- (2021) Narges K. Tafreshi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The Future of Cancer Diagnosis, Treatment and Surveillance: A Systemic Review on Immunotherapy and Immuno-PET Radiotracers
- (2021) Virginia Liberini et al. MOLECULES
- Emerging concepts in PD-1 checkpoint biology
- (2021) Kristen E. Pauken et al. SEMINARS IN IMMUNOLOGY
- Combination Therapy, a Promising Approach to Enhance the Efficacy of Radionuclide and Targeted Radionuclide Therapy of Prostate and Breast Cancer
- (2021) Tyrillshall S. T. Damiana et al. Pharmaceutics
- Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy
- (2021) J. Remon et al. ANNALS OF ONCOLOGY
- Multimodality labeling of NGR-functionalized hyaluronan for tumor targeting and radiotherapy
- (2021) Xiangyu Li et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Current and Future Development in Lung Cancer Diagnosis
- (2021) Reem Nooreldeen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer
- (2021) Anna-Larissa Nadia Niemeijer et al. JOURNAL OF NUCLEAR MEDICINE
- PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
- (2021) Jasper Smit et al. JOURNAL OF NUCLEAR MEDICINE
- First-in-human evaluation of a PD-L1-binding peptide radiotracer in non-small cell lung cancer patients with PET
- (2021) Xin Zhou et al. JOURNAL OF NUCLEAR MEDICINE
- Feasibility, Biodistribution and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy (PTRT) of Diverse Adenocarcinomas using 177Lu-FAP-2286: First-in-Human Results
- (2021) Richard P Baum et al. JOURNAL OF NUCLEAR MEDICINE
- Overcoming Chemotherapy Resistance in SCLC
- (2021) Brett H. Herzog et al. Journal of Thoracic Oncology
- Emerging role of natural products in cancer immunotherapy
- (2021) Songtao Dong et al. Acta Pharmaceutica Sinica B
- NSCLC Biomarkers to Predict Response to Immunotherapy with Checkpoint Inhibitors (ICI): From the Cells to In Vivo Images
- (2021) Virginia Liberini et al. Cancers
- Targeted Radionuclide Therapy Using Auger Electron Emitters: The Quest for the Right Vector and the Right Radionuclide
- (2021) Malick Bio Idrissou et al. Pharmaceutics
- International consensus on severe lung cancer—the first edition
- (2021) Chengzhi Zhou et al. Translational Lung Cancer Research
- Revisiting the Radiobiology of Targeted Alpha Therapy
- (2021) Jean-Pierre Pouget et al. Frontiers in Medicine
- 89Zr-pembrolizumab imaging as a non-invasive approach to assess clinical response to PD-1 blockade in cancer
- (2021) I.C. Kok et al. ANNALS OF ONCOLOGY
- PET/CT metabolic patterns in systemic immune activation: A new perspective on the assessment of immunotherapy response and efficacy
- (2021) Peng Jin et al. CANCER LETTERS
- Anticancer drug resistance: An update and perspective
- (2021) Ruth Nussinov et al. DRUG RESISTANCE UPDATES
- Optimizing immunoPET imaging of tumor PD-L1 expression: pharmacokinetics, biodistribution and dosimetric comparisons of 89Zr-labeled anti-PD-L1 antibody formats
- (2021) ALIZEE BOULEAU et al. JOURNAL OF NUCLEAR MEDICINE
- Molecular Targeted Positron Emission Tomography Imaging and Radionuclide Therapy of Pancreatic Ductal Adenocarcinoma
- (2021) Thomas T. Poels et al. Cancers
- The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015
- (2021) Andrew G. Nicholson et al. Journal of Thoracic Oncology
- Improving Tumor‐to‐Background Contrast Through Hydrophilic Tetrazines: The Construction of 18F Labeled PET Agents Targeting Non‐Small Cell Lung Carcinoma
- (2020) huijuan feng et al. CHEMISTRY-A EUROPEAN JOURNAL
- Theranostics: Leveraging Molecular Imaging and Therapy to Impact Patient Management and Secure the Future of Nuclear Medicine
- (2020) Lilja B. Solnes et al. JOURNAL OF NUCLEAR MEDICINE
- Synthesis and Evaluation of F Labeled Crizotinib Derivative [F]FPC as a Novel PET Probe for Imaging c-MET-positive NSCLC Tumor
- (2020) Qingyu Lin et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Click‐chemistry (CuAAC) trimerization of an αvβ6‐integrin targeting Ga‐68‐peptide: Enhanced contrast for in‐vivo PET imaging of human lung adenocarcinoma xenografts
- (2020) Neil Gerard Quigley et al. CHEMBIOCHEM
- Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy
- (2020) Chongxian Pan et al. Journal of Hematology & Oncology
- Diagnostic imaging of typical lung carcinoids: relationship between MDCT, 111In-Octreoscan and 18F-FDG-PET imaging features with Ki-67 index
- (2020) Ginevra Danti et al. Radiologia Medica
- Radiation dosimetry of 18F-AzaFol: A first in-human use of a folate receptor PET tracer
- (2020) Silvano Gnesin et al. EJNMMI Research
- Development of Novel 111-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours
- (2020) Benjamin Poret et al. Biomolecules
- Development of [89Zr]ZrDFO-amivantamab bispecific to EGFR and c-MET for PET imaging of triple-negative breast cancer
- (2020) Alessandra Cavaliere et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- FAPI-74 PET/CT Using Either 18F-AlF or Cold-kit 68Ga-labeling: Biodistribution, Radiation Dosimetry and Tumor Delineation in Lung Cancer Patients
- (2020) Frederik Giesel et al. JOURNAL OF NUCLEAR MEDICINE
- Synthesis and Fundamental Evaluation of Radioiodinated Rociletinib (CO-1686) as a Probe to Lung Cancer with L858R/T790M Mutations of Epidermal Growth Factor Receptor (EGFR)
- (2020) Muammar Fawwaz et al. MOLECULES
- Immuno-SPECT/PET imaging with radioiodinated anti-PD-L1 antibody to evaluate PD-L1 expression in immune-competent murine models and PDX model of lung adenocarcinoma
- (2020) Xuejun Wen et al. NUCLEAR MEDICINE AND BIOLOGY
- Radiotherapy treatment for lung cancer: Current status and future directions
- (2020) Shalini K. Vinod et al. RESPIROLOGY
- TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target
- (2020) Jiao-jiao Yu et al. Nature Communications
- Phase I study of the 177Lu-DOTA0-Tyr3-Octreotate (lutathera) in combination with nivolumab in patients with neuroendocrine tumors of the lung
- (2020) Chul Kim et al. Journal for ImmunoTherapy of Cancer
- 177Lu-labeled cyclic RGD peptide as an imaging and targeted radionuclide therapeutic agent in non-small cell lung cancer: Biological evaluation and preclinical study
- (2020) Nazanin Pirooznia et al. BIOORGANIC CHEMISTRY
- Combination Strategies to Improve Targeted Radionuclide Therapy
- (2020) Tiffany Chan et al. JOURNAL OF NUCLEAR MEDICINE
- Targeted Radionuclide Therapy in Patient-Derived Xenografts Using 177Lu-EB-RGD
- (2020) Liang Zhao et al. MOLECULAR CANCER THERAPEUTICS
- Evaluating 225Ac and 177Lu Radioimmunoconjugates against Antibody–Drug Conjugates for Small-Cell Lung Cancer
- (2020) Andrew L. Lakes et al. MOLECULAR PHARMACEUTICS
- Overview of Radiolabeled Somatostatin Analogs for Cancer Imaging and Therapy
- (2020) Romain Eychenne et al. MOLECULES
- Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC
- (2020) Roy S. Herbst et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quantification of [18F]afatinib using PET/CT in NSCLC patients: a feasibility study
- (2020) E. A. van de Stadt et al. EJNMMI Research
- TIGIT in cancer immunotherapy
- (2020) Joe-Marc Chauvin et al. Journal for ImmunoTherapy of Cancer
- Fibroblast Activation Protein Inhibitor PET/CT
- (2020) Punit Sharma et al. CLINICAL NUCLEAR MEDICINE
- Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy
- (2020) Richard L. Wahl et al. JOURNAL OF NUCLEAR MEDICINE
- The Future of Nuclear Medicine, Molecular Imaging, and Theranostics
- (2020) Wolfgang A. Weber et al. JOURNAL OF NUCLEAR MEDICINE
- Oxidative stress associated metabolic adaptations regulate radioresistance in human lung cancer cells
- (2020) Babita Singh et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- Biodistribution, pharmacokinetics and radioimmunotherapy of 188Re-cetuximab in NCI-H292 human lung tumor-bearing nude mice
- (2019) Ya-Jen Chang et al. INVESTIGATIONAL NEW DRUGS
- Early phase I study of a 99mTc labeled anti-PD-L1 single domain antibody in SPECT/CT assessment of programmed death ligand-1 expression in non-small cell lung cancer
- (2019) Yan Xing et al. JOURNAL OF NUCLEAR MEDICINE
- Peptide Receptor Radionuclide Therapy for Patients With Advanced Lung Carcinoids
- (2019) Boris G. Naraev et al. Clinical Lung Cancer
- Mesothelin-targeted thorium-227 conjugate (MSLN-TTC): Preclinical evaluation of a new targeted alpha therapy for mesothelin-positive cancers
- (2019) Urs B Hagemann et al. CLINICAL CANCER RESEARCH
- FAPI-PET/CT: Mean intensity of tracer-uptake (SUV) in 28 different kinds of cancer
- (2019) Clemens Kratochwil et al. JOURNAL OF NUCLEAR MEDICINE
- Potential for Nuclear Medicine Therapy for Glioblastoma Treatment
- (2019) Clément Bailly et al. Frontiers in Pharmacology
- Evaluation of Lung Cancer and Neuroendocrine Neoplasm in a Single Scan by Targeting Both Somatostatin Receptor and Integrin αvβ3
- (2019) Yumin Zheng et al. CLINICAL NUCLEAR MEDICINE
- Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine
- (2019) Thomas Langbein et al. JOURNAL OF NUCLEAR MEDICINE
- Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment
- (2019) Narjust Duma et al. MAYO CLINIC PROCEEDINGS
- Validation of [125I]CPCR4.3 as an investigative tool for the sensitive and specific detection of hCXCR4 and mCXCR4 expression in vitro and in vivo
- (2019) Margret Schottelius et al. EJNMMI Research
- Immuno-PET imaging for non-invasive assessment of cetuximab accumulation in non-small cell lung cancer
- (2019) Aiko Yamaguchi et al. BMC CANCER
- Broadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety
- (2019) Sanjana Ballal et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- [68Ga]Ga/[177Lu]Lu-BL01, a Novel Theranostic Pair for Targeting C-X-C Chemokine Receptor 4
- (2019) Joseph Lau et al. MOLECULAR PHARMACEUTICS
- Evaluation of 64Cu radiolabeled anti-hPD-L1 Nb6 for positron emission tomography imaging in lung cancer tumor mice model
- (2019) Jinquan Jiang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Quantitative PET imaging of PD-L1 expression in xenograft and syngeneic tumour models using a site-specifically labelled PD-L1 antibody
- (2019) Camilla Christensen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee
- (2019) Sylvie Lantuejoul et al. Journal of Thoracic Oncology
- 177Lu-DOTATATE peptide receptor radionuclide therapy versus Everolimus in advanced pancreatic neuroendocrine tumors
- (2019) Swayamjeet Satapathy et al. NUCLEAR MEDICINE COMMUNICATIONS
- Targeted Radionuclide Therapy: A Historical and Personal Review
- (2019) Stanley J. Goldsmith SEMINARS IN NUCLEAR MEDICINE
- Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients
- (2018) J Remon et al. ANNALS OF ONCOLOGY
- Tricine co-ligand improved the efficacy of 99m Tc-HYNIC-(Ser) 3 -J18 peptide for targeting and imaging of non-small-cell lung cancer
- (2018) Zahra Shaghaghi et al. BIOMEDICINE & PHARMACOTHERAPY
- Radiosynthesis and biological evaluation of 18 F-labeled 4-anilinoquinazoline derivative ( 18 F-FEA-Erlotinib) as a potential EGFR PET agent
- (2018) Shun Huang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- CLR 125 Auger Electrons for the Targeted Radiotherapy of Triple-Negative Breast Cancer
- (2018) Joseph Grudzinski et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Comparing the Differential Diagnostic Values of 18F-Alfatide II PET/CT between Tuberculosis and Lung Cancer Patients
- (2018) Xiaoqing Du et al. Contrast Media & Molecular Imaging
- Stereotactic Body Radiotherapy for Early-Stage Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline
- (2018) Bryan J. Schneider et al. JOURNAL OF CLINICAL ONCOLOGY
- Development of quinoline based theranostic ligands for the targeting of fibroblast activation protein
- (2018) Thomas Lindner et al. JOURNAL OF NUCLEAR MEDICINE
- Development of a Novel SPECT Tracer to Image c-Met Expression in Non-Small Cell Lung Cancer in a Human Tumor Xenograft
- (2018) Zhaoguo Han et al. JOURNAL OF NUCLEAR MEDICINE
- Advancing Targeted Radionuclide Therapy through the National Cancer Institute’s Small Business Innovation Research Pathway
- (2018) Kaveh Zakeri et al. JOURNAL OF NUCLEAR MEDICINE
- Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer
- (2018) Shang-Gin Wu et al. Molecular Cancer
- Third generation EGFR TKIs: current data and future directions
- (2018) Chee-Seng Tan et al. Molecular Cancer
- Noninvasive Trafficking of Brentuximab Vedotin and PET Imaging of CD30 in Lung Cancer Murine Models
- (2018) Lei Kang et al. MOLECULAR PHARMACEUTICS
- Design, Synthesis, and Biological Evaluation of 68Ga-DOTA–PA1 for Lung Cancer: A Novel PET Tracer for Multiple Somatostatin Receptor Imaging
- (2018) Fei Liu et al. MOLECULAR PHARMACEUTICS
- A PET imaging approach for determining EGFR mutation status for improved lung cancer patient management
- (2018) Xilin Sun et al. Science Translational Medicine
- Preclinical Development and First-in-Human Imaging of the Integrin αvβ6 with [18F]αvβ6-Binding Peptide in Metastatic Carcinoma
- (2018) Sven H. Hausner et al. CLINICAL CANCER RESEARCH
- 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer
- (2018) Frederike Bensch et al. NATURE MEDICINE
- TARGETED ALPHA PARTICLE THERAPY FOR NEUROENDOCRINE TUMOURS: THE NEXT GENERATION OF PRRT
- (2018) Ashley Grossman et al. NEUROENDOCRINOLOGY
- Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer
- (2018) A. N. Niemeijer et al. Nature Communications
- Product review: avelumab, an anti-PD-L1 antibody
- (2018) Julie M. Collins et al. Human Vaccines & Immunotherapeutics
- Synthesis and preliminary evaluation of 18F-icotinib for EGFR-targeted PET imaging of lung cancer
- (2018) Xinmiao Lu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Inter-heterogeneity and intra-heterogeneity of αvβ3 in non-small cell lung cancer and small cell lung cancer patients as revealed by 68Ga-RGD2 PET imaging
- (2017) Fei Kang et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 89Zr-Onartuzumab PET imaging of c-MET receptor dynamics
- (2017) Martin Pool et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68Ga-Pentixafor PET/CT demonstrating higher CXCR4 density in small cell lung carcinoma than in non-small cell variant
- (2017) Ankit Watts et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells
- (2017) Mohammad Rashidian et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Response Assessment of68Ga-DOTA-E-[c(RGDfK)]2PET/CT in Lung Adenocarcinoma Patients Treated with Nintedanib Plus Docetaxel
- (2017) Oscar Arrieta et al. JOURNAL OF NUCLEAR MEDICINE
- 68 Ga-DOTATOC Imaging of Neuroendocrine Tumors: A Systematic Review and Metaanalysis
- (2017) Michael M. Graham et al. JOURNAL OF NUCLEAR MEDICINE
- Synthesis and Biologic Evaluation of a Novel18F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 Expression
- (2017) David J. Donnelly et al. JOURNAL OF NUCLEAR MEDICINE
- Driven by Mutations: The Predictive Value of Mutation Subtype in EGFR -Mutated Non–Small Cell Lung Cancer
- (2017) Emily Castellanos et al. Journal of Thoracic Oncology
- Targeted radionuclide therapy in combined-modality regimens
- (2017) Martin R Gill et al. LANCET ONCOLOGY
- A nanobody targeting carcinoembryonic antigen as a promising molecular probe for non-small cell lung cancer
- (2017) Hao Wang et al. Molecular Medicine Reports
- CD38 as a PET Imaging Target in Lung Cancer
- (2017) Emily B. Ehlerding et al. MOLECULAR PHARMACEUTICS
- ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer
- (2017) Christopher G. England et al. MOLECULAR PHARMACEUTICS
- ImmunoPET Imaging of CTLA-4 Expression in Mouse Models of Non-small Cell Lung Cancer
- (2017) Emily B. Ehlerding et al. MOLECULAR PHARMACEUTICS
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer
- (2017) Judith van Loon et al. RADIOTHERAPY AND ONCOLOGY
- Development and Evaluation of 18F-IRS for Molecular Imaging Mutant EGF Receptors in NSCLC
- (2017) Yan Song et al. Scientific Reports
- Quantitative Imaging for Targeted Radionuclide Therapy Dosimetry - Technical Review
- (2017) Tiantian Li et al. Theranostics
- The Use of PET Imaging for Prognostic Integrin α2β1 Phenotyping to Detect Non-Small Cell Lung Cancer and Monitor Drug Resistance Responses
- (2017) Chiun-Wei Huang et al. Theranostics
- Triple targeting of Auger emitters using octreotate conjugated to a DNA-binding ligand and a nuclear localizing signal
- (2016) John A. Violet et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- In Vivo PET Imaging of the Cancer Integrin αvβ6 Using 68 Ga-Labeled Cyclic RGD Nonapeptides
- (2016) Johannes Notni et al. JOURNAL OF NUCLEAR MEDICINE
- First Experience with Chemokine Receptor CXCR4-Targeted PET Imaging of Patients with Solid Cancers
- (2016) T. Vag et al. JOURNAL OF NUCLEAR MEDICINE
- Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors
- (2016) S. A. Deppen et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis
- (2016) S. A. Deppen et al. JOURNAL OF NUCLEAR MEDICINE
- The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer
- (2016) Andrew G. Nicholson et al. Journal of Thoracic Oncology
- Predictive biomarkers for checkpoint inhibitor-based immunotherapy
- (2016) Geoffrey T Gibney et al. LANCET ONCOLOGY
- The role of new PET tracers for lung cancer
- (2016) Teresa A. Szyszko et al. LUNG CANCER
- Re-188 Enhances the Inhibitory Effect of Bevacizumab in Non-Small-Cell Lung Cancer
- (2016) Jie Xiao et al. MOLECULES
- Integrin Imaging with 99mTc-3PRGD2 SPECT/CT Shows High Specificity in the Diagnosis of Lymph Node Metastasis from Non–Small Cell Lung Cancer
- (2016) Xiaona Jin et al. RADIOLOGY
- A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts
- (2016) Babak Behnam Azad et al. Oncotarget
- Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy
- (2016) Constantin Lapa et al. Oncotarget
- Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
- (2016) Haojun Chen et al. Theranostics
- First-In-Human Study Demonstrating Tumor-Angiogenesis by PET/CT Imaging with68Ga-NODAGA-THERANOST, a High-Affinity Peptidomimetic for αvβ3Integrin Receptor Targeting
- (2015) Richard P. Baum et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- [68Ga]-HP-DO3A-nitroimidazole: a promising agent for PET detection of tumor hypoxia
- (2015) Yunkou Wu et al. Contrast Media & Molecular Imaging
- A pilot study imaging integrin αvβ3 with RGD PET/CT in suspected lung cancer patients
- (2015) Song Gao et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Targeted Radionuclide Therapy of Human Tumors
- (2015) Sergey Gudkov et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Comparing the Diagnostic Potential of 68Ga-Alfatide II and 18F-FDG in Differentiating Between Non-Small Cell Lung Cancer and Tuberculosis
- (2015) F. Kang et al. JOURNAL OF NUCLEAR MEDICINE
- PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab
- (2015) H. Luo et al. JOURNAL OF NUCLEAR MEDICINE
- Triple-Peptide Receptor Targeting In Vitro Allows Detection of All Tested Gut and Bronchial NETs
- (2015) J. C. Reubi et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga-NOTA-PRGD2 PET/CT for Integrin Imaging in Patients with Lung Cancer
- (2015) K. Zheng et al. JOURNAL OF NUCLEAR MEDICINE
- Chemoradiotherapeutic Magnetic Nanoparticles for Targeted Treatment of Nonsmall Cell Lung Cancer
- (2015) Imalka Munaweera et al. MOLECULAR PHARMACEUTICS
- Tumor necrosis targeted radiotherapy of non-small cell lung cancer using radioiodinated protohypericin in a mouse model
- (2015) Xuejiao Liu et al. Oncotarget
- Pilot Prospective Evaluation of 18F-Alfatide II for Detection of Skeletal Metastases
- (2015) Baoming Mi et al. Theranostics
- Peptide receptor chemoradionuclide therapy in small cell carcinoma: from bench to bedside
- (2014) Jeremy Lewin et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- In Vivo Visualization of MET Tumor Expression and Anticalin Biodistribution with the MET-Specific Anticalin 89Zr-PRS-110 PET Tracer
- (2014) A. G. T. Terwisscha van Scheltinga et al. JOURNAL OF NUCLEAR MEDICINE
- Anti-MET ImmunoPET for Non-Small Cell Lung Cancer Using Novel Fully Human Antibody Fragments
- (2014) K. Li et al. MOLECULAR CANCER THERAPEUTICS
- Diagnostic role of Gallium-68 DOTATOC and Gallium-68 DOTATATE PET in patients with neuroendocrine tumors: a meta-analysis
- (2013) Jigang Yang et al. ACTA RADIOLOGICA
- Advances in Anticancer Radiopharmaceuticals
- (2013) M.R. Jackson et al. CLINICAL ONCOLOGY
- First Experience of 18F-Alfatide in Lung Cancer Patients Using a New Lyophilized Kit for Rapid Radiofluorination
- (2013) W. Wan et al. JOURNAL OF NUCLEAR MEDICINE
- Bone-Seeking Radiopharmaceuticals for Treatment of Osseous Metastases, Part 1: Therapy with 223Ra-Dichloride
- (2013) N. Pandit-Taskar et al. JOURNAL OF NUCLEAR MEDICINE
- Imaging of bronchioloalveolar carcinoma in the mice with the αⅤβ3 integrin-targeted tracer 99mTc-RGD-4CK
- (2013) Bin Liu et al. Translational Research
- In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapy
- (2012) Hiroki Yoshioka et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Development of [11C]erlotinib Positron Emission Tomography for In Vivo Evaluation of EGF Receptor Mutational Status
- (2012) I. Bahce et al. CLINICAL CANCER RESEARCH
- 99mTc-3PRGD2 for Integrin Receptor Imaging of Lung Cancer: A Multicenter Study
- (2012) Z. Zhu et al. JOURNAL OF NUCLEAR MEDICINE
- EGFR Mutations and Lung Cancer
- (2011) Gilda da Cunha Santos et al. Annual Review of Pathology-Mechanisms of Disease
- Clinical results of radionuclide therapy of neuroendocrine tumours with 90Y-DOTATATE and tandem 90Y/177Lu-DOTATATE: which is a better therapy option?
- (2011) Jolanta Kunikowska et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68Ga-DOTATOC Versus 68Ga-DOTATATE PET/CT in Functional Imaging of Neuroendocrine Tumors
- (2011) T. D. Poeppel et al. JOURNAL OF NUCLEAR MEDICINE
- Molecular Imaging with 11C-PD153035 PET/CT Predicts Survival in Non-Small Cell Lung Cancer Treated with EGFR-TKI: A Pilot Study
- (2011) X. Meng et al. JOURNAL OF NUCLEAR MEDICINE
- PET of CXCR4 Expression by a 68Ga-Labeled Highly Specific Targeted Contrast Agent
- (2011) E. Gourni et al. JOURNAL OF NUCLEAR MEDICINE
- Positron Emission Tomography Imaging of Tumors Expressing the Human Chemokine Receptor CXCR4 in Mice with the Use of 64Cu-AMD3100
- (2011) Ido D. Weiss et al. MOLECULAR IMAGING AND BIOLOGY
- Pilot Pharmacokinetic and Dosimetric Studies of18F-FPPRGD2: A PET Radiopharmaceutical Agent for Imaging αvβ3Integrin Levels
- (2011) Erik S. Mittra et al. RADIOLOGY
- Targeted Radionuclide Therapy
- (2011) Devrim Ersahin et al. Cancers
- Molecular Imaging of CXCR4 Receptor Expression in Human Cancer Xenografts with [64Cu]AMD3100 Positron Emission Tomography
- (2010) S. Nimmagadda et al. CANCER RESEARCH
- A Phase II study of anti–epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme
- (2010) Linna Li et al. JOURNAL OF NEUROSURGERY
- Targeted Radiopharmaceutical Therapy for Advanced Lung Cancer: Phase I Trial of Rhenium Re188 P2045, a Somatostatin Analog
- (2010) Martin J. Edelman et al. Journal of Thoracic Oncology
- Noninternalizing Monoclonal Antibodies Are Suitable Candidates for 125I Radioimmunotherapy of Small-Volume Peritoneal Carcinomatosis
- (2009) L. Santoro et al. JOURNAL OF NUCLEAR MEDICINE
- 18F-Labeled Galacto and PEGylated RGD Dimers for PET Imaging of αvβ3 Integrin Expression
- (2009) Shuanglong Liu et al. MOLECULAR IMAGING AND BIOLOGY
- Imaging of integrin αvβ3 expression
- (2008) Ambros J. Beer et al. CANCER AND METASTASIS REVIEWS
- Evaluation of [18F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors
- (2008) Helen Su et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The value of gamma camera and computed tomography data set coregistration to assess Lewis Y antigen targeting in small cell lung cancer by 111Indium-labeled humanized monoclonal antibody 3S193
- (2007) Emilio Quaia et al. EUROPEAN JOURNAL OF RADIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now